Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -265,939 | -193,506 | -80,736 | -71,038 | -6,553 |
| Depreciation Amortization | 4,323 | 3,786 | 2,983 | 2,109 | 2,421 |
| Accounts receivable | 1,738 | -6,209 | -4,854 | -190 | -8,883 |
| Accounts payable and accrued liabilities | -887 | -318 | 583 | -621 | 1,796 |
| Other Working Capital | 7,710 | -10,230 | -7,411 | 1,349 | -2,901 |
| Other Operating Activity | 48,172 | 71,800 | 19,201 | 8,788 | -51,430 |
| Operating Cash Flow | $-204,883 | $-134,677 | $-70,234 | $-59,603 | $-65,550 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,880 | -1,288 | -6,087 | -3,715 | -1,194 |
| Investing Cash Flow | $-11,880 | $-1,288 | $-6,087 | $-3,715 | $-1,194 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 0 | 2,000 | 0 | 0 |
| Debt Issued | 0 | 0 | 82,474 | 0 | 3,722 |
| Debt Repayment | 0 | 0 | -26,125 | 0 | -4,167 |
| Common Stock Issued | 561,721 | 332,110 | 118,663 | 1,454 | 3,571 |
| Other Financing Activity | 0 | 0 | -7,184 | 0 | -275 |
| Financing Cash Flow | $561,721 | $332,110 | $169,828 | $1,454 | $2,851 |
| Beginning Cash Position | 393,716 | 197,571 | 104,064 | 165,928 | 229,821 |
| End Cash Position | 738,674 | 393,716 | 197,571 | 104,064 | 165,928 |
| Net Cash Flow | $344,958 | $196,145 | $93,507 | $-61,864 | $-63,893 |
| Free Cash Flow | |||||
| Operating Cash Flow | -204,883 | -134,677 | -70,234 | -59,603 | -65,550 |
| Capital Expenditure | -12,010 | -1,288 | -6,087 | -3,715 | -1,194 |
| Free Cash Flow | -216,893 | -135,965 | -76,321 | -63,318 | -66,744 |